Drug Development in a Time of Ebola

Forbes kicked off the 2014 Healthcare Summit with this session titled, “Drug Development in A Time of Ebola.” Forbes senior editor Matthew Herper interviewed Edward Cox and Lucianna Borio, two high-ranking officials at the U.S. Food and Drug Administration (FDA).

Cox leads the Office of Antimicrobial Products along with the Center for Drug Evaluation and Research, while Borio serves as the Assistant Commissioner for Counterterrorism Policy.

Herper interviewed Cox and Borio on the subject of drug development during a time when the world is dealing with an onslaught of diseases.